<DOC>
	<DOCNO>NCT02152566</DOCNO>
	<brief_summary>Respiratory insufficiency sleep lead reduction level oxygen blood night , show contribute range morbidity . The purpose study assess possibility nasal high flow therapy device may able treat respiratory insufficiency , stabilize breathe prevent reduction blood oxygen . Heart failure patient screen heart failure clinic , ask undergo overnight sleep study determine exhibit respiratory insufficiency sleep . This sleep study may complete sleep laboratory ( attended polysomnography , PSG ) in-home ( in-home polygraphy , PG ) . If diagnosed respiratory insufficiency , ask attend overnight study see treatment nasal high flow therapy use stabilize breathing .</brief_summary>
	<brief_title>Nasal High Flow Therapy Treatment Respiratory Insufficiencies During Sleep</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<criteria>Men Women age ≥ 18 year Heart Failure ischemic nonischemic dilate cardiomyopathy ≥ 6 month Left ventricular systolic dysfunction ( LVEF ≤45 % echocardiography perform within 3 month screen visit , within 3 month , justification provide cardiologist repeat echocardiography require , example , subject 's condition remain stable since echocardiography ) . All echocardiography must within maximum 1 year screen visit . New York Heart Association Class II III optimization medical therapy Stable Clinical Status stable optimal medical therapy ≥ 1 month entry Unstable angina Myocardial infarction within last 12 month Cardiac surgery within previous 6 month Pregnancy Unwilling unable provide inform consent Uncontrolled arrhythmias Severe valvular heart disease Current/prior use mechanical ventilation ( include CPAP ) . At investigator 's discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>